Ibach Mitch

Ferguson Tanner J, Swan Russell J, Bleeker Adam, Dockter Zachary, Karpuk Kayla L, Schweitzer Justin et al.

iStent with cataract surgery in pseudoexfoliative glaucoma safely reduced eye pressure long-term (5 years), but medication reduction was not sustained, offering a good safety profile for IOP control.

Ferguson Tanner J, Ibach Mitch, Schweitzer Justin, Karpuk Kayla L, Stephens John D, Berdahl John P

This study found trabecular micro-bypass stents with cataract surgery effectively and safely lowered eye pressure for up to three years in pigmentary glaucoma patients.

Ferguson Tanner J, Ibach Mitch, Schweitzer Justin, Karpuk Kayla, Stephens J David, Sudhagoni Ramu et al.

A study of pseudophakic glaucoma patients found a single trabecular microbypass stent safely and effectively lowered eye pressure long-term, especially in those with higher baseline pressures, reducing medication needs.

Ferguson Tanner, Swan Russell, Ibach Mitch, Schweitzer Justin, Sudhagoni Ramu, Berdahl John P

This study found trabecular microbypass stents with cataract surgery safely lowered eye pressure and medication use in severe glaucoma, offering a combined treatment option.

Kindle Trevor, Ferguson Tanner, Ibach Mitch, Greenwood Michael, Schweitzer Justin, Swan Russell et al.

This study found intravitreal steroid/antibiotics during cataract surgery with stent insertion was as safe as topical drops, with similar IOP and medication reduction, offering a potential alternative regimen.

Ferguson Tanner J, Swan Russell, Ibach Mitch, Schweitzer Justin, Sudhagoni Ramu, Berdahl John P

This study found that iStent implantation with cataract surgery safely and effectively lowered eye pressure and reduced medication use in pseudoexfoliation glaucoma patients, offering a valuable treatment option.